4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-036362
Chief Commercial Officer sold 16,074 shares at $7.50 ($120,528)
From the SEC's structured data for this filing
Trades in this filing
VAN BEEK JEROEN B · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-16 | Sale : show line 1 in the form | −16,074 | $7.50 | $120,528 | 333,726 | D |
| Open-market sales · 16,074 sh · avg $7.50 · $120,528 | ||||||
Loading xslF345X03/doc4.xml…